Daniela Raizin

Daniela Raizin is an accomplished finance professional currently serving as the Executive Director of Finance at Revolution Medicines since April 2024. Previously, Daniela held the position of Senior Director of SEC Reporting and Technical Accounting at EQRx, which was acquired by Revolution Medicines, from September 2022 to November 2023. Daniela gained extensive experience as Controller for the Americas at Element Materials Technology from 2021 to September 2022 and spent over a decade at PwC in various roles, including Director, Senior Manager, Manager, and Senior Associate. Daniela began their career as an intern in the Corporate Banking Department at Raiffeisenbank (Bulgaria) EAD in 2007. Daniela holds a Bachelor of Science in Economics from Sofia University St. Kliment Ohridski and is currently pursuing a Master's Degree in Finance and Banking from the same institution.